ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
121.783,61
-0,46%
S&P 500
5.996,66
1,00%
US Dollar vs BRL
6,0752
-0,09%
Bitcoin
107.886,05
4,63%
Brent Oil
79,795
-0,52%
As Melhores Corretoras Online
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. SciSparc Ltd (SPRC)

  7. SciSparc Ltd (SPRC) Notícias

SPRC

SciSparc (SPRC)

SciSparc Ltd
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:SPRC
DataHoraFonteTítuloCódigoCompanhia
15/01/202518:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SPRCSciSparc Ltd
15/01/202509:34GlobeNewswire Inc.SciSparc Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid RequirementNASDAQ:SPRCSciSparc Ltd
13/01/202510:41GlobeNewswire Inc.SciSparc: AutoMax Enters the Direct Import Market with a $13 Million First Shipment of JAC Electric VehiclesNASDAQ:SPRCSciSparc Ltd
07/01/202509:25GlobeNewswire Inc.SciSparc: MitoCareX Bio Expands Research to Pancreatic Cancer Following Initial In-Vitro Positive ResultsNASDAQ:SPRCSciSparc Ltd
06/01/202509:50GlobeNewswire Inc.SciSparc-Clearmind Medicine Collaboration Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination TreatmentNASDAQ:SPRCSciSparc Ltd
31/12/202418:16Edgar (US Regulatory)Form F-4/A - Registration of securities, foreign private issuers, business combinations: [Amend]NASDAQ:SPRCSciSparc Ltd
31/12/202411:24GlobeNewswire Inc.SciSparc Announces Renewal of Approval by Israeli Medical Cannabis Agency for its Clinical Trial in Children with Autism Spectrum DisorderNASDAQ:SPRCSciSparc Ltd
26/12/202418:06Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:SPRCSciSparc Ltd
26/12/202408:46GlobeNewswire Inc.SciSparc: AutoMax Announces $13 Million First Delivery of JAC Vehicles Following Regulatory Approval for Direct ImportationNASDAQ:SPRCSciSparc Ltd
16/12/202409:40GlobeNewswire Inc.SciSparc Provides Updates on Status of Spin-off of its Advanced Clinical Stage Pharmaceutical Portfolio to a Publicly Traded CompanyNASDAQ:SPRCSciSparc Ltd
30/09/202410:25GlobeNewswire Inc.SciSparc Secures FDA Green Light to US Launch of its Pivotal Phase IIb Clinical Trial for Breakthrough Tourette Syndrome TreatmentNASDAQ:SPRCSciSparc Ltd
26/09/202410:05GlobeNewswire Inc.SciSparc Signs Non-Binding Letter of Intent to Sell Stake in MitoCareXNASDAQ:SPRCSciSparc Ltd
23/09/202409:17GlobeNewswire Inc.SciSparc Receives FDA Approval to Initiate Phase IIb Clinical Trial for Tourette Syndrome TreatmentNASDAQ:SPRCSciSparc Ltd
18/09/202417:09GlobeNewswire Inc.SciSparc Takes Major Step Forward with IND Application submitted to the FDA for Phase IIb Clinical Trial for Tourette Syndrome TreatmentNASDAQ:SPRCSciSparc Ltd
16/09/202417:06GlobeNewswire Inc.SciSparc-Clearmind Medicine Collaboration Announces the Publication of an International Patent Application for Pioneering Ibogaine Combination TherapyNASDAQ:SPRCSciSparc Ltd
11/09/202408:40GlobeNewswire Inc.SciSparc Advances $1.85 million Loan to AutoMax, Following AutoMax’s Direct Import Agreement with Major Chinese Vehicle ManufacturerNASDAQ:SPRCSciSparc Ltd
06/09/202408:55GlobeNewswire Inc.SciSparc-Clearmind Medicine Collaboration Leads to Publication of International Patent Application for Innovative MDMA-Based Combination TreatmentNASDAQ:SPRCSciSparc Ltd
06/09/202408:55GlobeNewswire Inc.Clearmind Medicine Announces Publication of International Patent Application for Innovative MDMA-Based Combination TreatmentNASDAQ:SPRCSciSparc Ltd
06/09/202401:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SPRCSciSparc Ltd
29/08/202417:25GlobeNewswire Inc.SciSparc-Clearmind Medicine Collaboration Leads to Publication of Application for Innovative Ketamine-Based CombinationNASDAQ:SPRCSciSparc Ltd
28/08/202417:05Edgar (US Regulatory)Form F-1 - Registration statement for certain foreign private issuersNASDAQ:SPRCSciSparc Ltd
28/08/202409:55GlobeNewswire Inc.SciSparc Grants Global Rights for Pain Therapy to Biotech Company in Agreement Worth up to $6 MillionNASDAQ:SPRCSciSparc Ltd
23/08/202417:09GlobeNewswire Inc.SciSparc Submitted IND Application to the FDA for SCI-110 Phase IIb Clinical Trial for Patients with Tourette SyndromeNASDAQ:SPRCSciSparc Ltd
22/08/202409:12GlobeNewswire Inc.SciSparc: MitoCareX Appointed Professor Nir Peled, Seasoned Oncologist, to its Scientific Advisory BoardNASDAQ:SPRCSciSparc Ltd
19/08/202417:11GlobeNewswire Inc.SciSparc Announces Enrollment of the First Five Patients in the Clinical Trial of its Innovative SCI-210 TreatmentNASDAQ:SPRCSciSparc Ltd
16/08/202417:30GlobeNewswire Inc.SciSparc Finalizes Exclusive Global Out-Licensing Agreement for its Pain Therapy Valued at $3 millionNASDAQ:SPRCSciSparc Ltd
14/08/202417:53GlobeNewswire Inc.SciSparc Updates Regarding the Status of the AutoMax MergerNASDAQ:SPRCSciSparc Ltd
06/08/202409:57GlobeNewswire Inc.SciSparc’s Collaboration with Clearmind Medicine Continues to Bear Fruit With New Scientific Article Showing MEAI Potential as a Novel Weight Loss DrugNASDAQ:SPRCSciSparc Ltd
17/07/202408:07GlobeNewswire Inc.SciSparc Signs Non-Binding Letter of Intent for Exclusive Global Out-Licensing of Pain Treatment for Approximately $6 millionNASDAQ:SPRCSciSparc Ltd
16/07/202412:55GlobeNewswire Inc.SciSparc Ltd. Announces Receipt of Nasdaq Minimum Bid Price NotificationNASDAQ:SPRCSciSparc Ltd
 Apresentando as notícias mais relevantes sobre:NASDAQ:SPRC

Seu Histórico Recente

TG
A5SA
Aston Martin Lagonda Glo...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados